<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Database (Oxford)</journal-id>
    <journal-id journal-id-type="iso-abbrev">Database (Oxford)</journal-id>
    <journal-id journal-id-type="publisher-id">databa</journal-id>
    <journal-title-group>
      <journal-title>Database: The Journal of Biological Databases and Curation</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1758-0463</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
      <publisher-loc>UK</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8271126</article-id>
    <article-id pub-id-type="doi">10.1093/database/baab041</article-id>
    <article-id pub-id-type="publisher-id">baab041</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Article</subject>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00960</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>TIDB: a comprehensive database of trained immunity</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7787-8506</contrib-id>
        <name>
          <surname>Cao</surname>
          <given-names>Yang</given-names>
        </name>
        <xref rid="FN1" ref-type="author-notes"/>
        <aff><institution content-type="department">Department of Environmental Medicine, Tianjin Institute of Environmental and Operational Medicine</institution>, No.1 Dali Road, Heping District, Tianjin 300050, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Dong</surname>
          <given-names>Qingyang</given-names>
        </name>
        <xref rid="FN1" ref-type="author-notes"/>
        <aff><institution content-type="department">Department of Environmental Medicine, Tianjin Institute of Environmental and Operational Medicine</institution>, No.1 Dali Road, Heping District, Tianjin 300050, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Dan</given-names>
        </name>
        <xref rid="FN1" ref-type="author-notes"/>
        <aff><institution content-type="department">State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics</institution>, No.38 Life Science Park Road, Changping District, Beijing 102206, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Ying</given-names>
        </name>
        <aff><institution content-type="department">Department of Environmental Medicine, Tianjin Institute of Environmental and Operational Medicine</institution>, No.1 Dali Road, Heping District, Tianjin 300050, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Pengcheng</given-names>
        </name>
        <aff><institution content-type="department">Department of Environmental Medicine, Tianjin Institute of Environmental and Operational Medicine</institution>, No.1 Dali Road, Heping District, Tianjin 300050, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yu</surname>
          <given-names>Xiaobo</given-names>
        </name>
        <!--xiaobo.yu@hotmail.com-->
        <xref rid="COR0001" ref-type="corresp"/>
        <aff><institution content-type="department">State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics</institution>, No.38 Life Science Park Road, Changping District, Beijing 102206, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Niu</surname>
          <given-names>Chao</given-names>
        </name>
        <!--niuchao601@126.com-->
        <xref rid="COR0002" ref-type="corresp"/>
        <aff><institution content-type="department">Department of Environmental Medicine, Tianjin Institute of Environmental and Operational Medicine</institution>, No.1 Dali Road, Heping District, Tianjin 300050, <country country="CN">China</country></aff>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR0001">*Corresponding author: Tel: +86-10-61777093; Fax: +86-10-61777050; Email: <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="xiaobo.yu@hotmail.com">xiaobo.yu@hotmail.com</email></corresp>
      <corresp id="COR0002">Correspondence may also be addressed to Chao Niu. Tel: +86-22-84655427; Fax: +86-22-84655018; Email: <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="niuchao601@126.com">niuchao601@126.com</email></corresp>
      <fn id="FN1">
        <label>
          <sup>†</sup>
        </label>
        <p>Yang Cao, ingyang Dong and Dan Wang contributed equally to this work.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2021-07-09">
      <day>09</day>
      <month>7</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>09</day>
      <month>7</month>
      <year>2021</year>
    </pub-date>
    <volume>2021</volume>
    <elocation-id>baab041</elocation-id>
    <history>
      <date date-type="received">
        <day>07</day>
        <month>12</month>
        <year>2020</year>
      </date>
      <date date-type="rev-recd">
        <day>21</day>
        <month>6</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>25</day>
        <month>6</month>
        <year>2021</year>
      </date>
      <date date-type="editorial-decision">
        <day>23</day>
        <month>6</month>
        <year>2021</year>
      </date>
      <date date-type="corrected-typeset">
        <day>07</day>
        <month>7</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2021. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2020</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="baab041.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>Trained immunity is a newly emerging concept that defines the ability of the innate immune system to form immune memory and provide long-lasting protection against previously encountered antigens. Accumulating evidence reveals that trained immunity not only has broad benefits to host defense but is also harmful to the host in chronic inflammatory diseases. However, all trained immunity-related information is scattered in the literature and thus is difficult to access. Here, we describe Trained Immunity DataBase (TIDB), a comprehensive database that provides well-studied trained immunity-related genes from human, rat and mouse as well as the related literature evidence. Moreover, TIDB also provides three modules to analyze the function of the trained-immunity-related genes of interest, including Reactome pathway over-representation analysis, Gene Ontology enrichment analysis and protein–protein interaction subnetwork reconstruction. We believe TIDB will help developing valuable strategies for vaccine design and immune-mediated disease therapy.</p>
      <p>
        <bold>Database URL:</bold>
        <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ieom-tm.com/tidb" ext-link-type="uri">http://www.ieom-tm.com/tidb</ext-link>
      </p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Tianjin Institute of Environmental and Operational Medicine</institution>
          </institution-wrap>
        </funding-source>
        <award-id>BWS17J025, BWS17J031</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="8"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec id="s1">
    <title>Introduction</title>
    <p>Traditionally, it has been known that immunological memory is an exclusive hallmark of the adaptive immune response. However, accumulated evidence shows that innate immune responses can also build long-lasting memory to protect against previously encountered antigens, which has been termed as ‘trained immunity’ by Netea (<xref rid="R1" ref-type="bibr">1–4</xref>). Over the past few years, many studies have proven that prototypical innate immune cells such as natural killer cells and monocytes/macrophages also display a long-term adaptation and enhanced responsiveness to certain stimuli after infection or vaccination (<xref rid="R3" ref-type="bibr">3–5</xref>). Trained immunity has changed our perspective of host defense and immunological memory and could provide a new strategy for vaccine design and disease therapy (<xref rid="R6" ref-type="bibr">6–9</xref>).</p>
    <p>Studies show that trained immunity in different microenvironments can be either beneficial or harmful to the host. For example, BCG vaccination protects the host against heterologous infections and malignancies through trained macrophage, which is independent of adaptive immunity (<xref rid="R10" ref-type="bibr">10</xref>). However, cancer cells can also induce epigenetic reprograming in innate immune cells through many mediators (<xref rid="R11" ref-type="bibr">11</xref>). These trained cell-secreted cytokines such as IL-6 and TNF could increase tumorigenicity and the spread of metastases in oral squamous cell carcinoma and lung, kidney and breast cancer (<xref rid="R12" ref-type="bibr">12</xref>, <xref rid="R13" ref-type="bibr">13</xref>).</p>
    <p>One of the most important mechanisms in trained immunity is metabolic and epigenetic rewiring, which convert oxidative phosphorylation to aerobic glycolysis and result in a pro-inflammatory response (<xref rid="R14" ref-type="bibr">14</xref>). <italic toggle="yes">Candida albicans</italic>, β-glucan and BCG vaccination can induce epigenetic remodeling through different pathways (<xref rid="R15" ref-type="bibr">15–17</xref>), which include the dectin-1-dependent and NOD2-dependent pathway (<xref rid="R18" ref-type="bibr">18</xref>, <xref rid="R19" ref-type="bibr">19</xref>). As described in previous reports, induction or suppression of trained immunity achieved through the modulation of these pathways could be therapeutically exploited in some diseases (<xref rid="R19" ref-type="bibr">19</xref>, <xref rid="R20" ref-type="bibr">20</xref>). The mechanisms underlying the above phenomena related to trained immunity rely deeply on the variation of gene expression.</p>
    <p>However, all trained immunity-related information is dispersed in the literature. A comprehensive set of well-annotated trained immunity-related genes would contribute significantly to the understanding of the role of trained immunity in health and disease. To meet this need, we built TIDB, which collects all previously identified genes associated with trained immunity from three species (human, rat and mouse) using text-mining and manual curation.</p>
    <sec id="s1-s1">
      <title>Data collection and manual curation</title>
      <p>TIDB is a manually curated database of trained immunity-related genes (<xref rid="F1" ref-type="fig">Figure 1</xref>). Each entry is extracted from the PubMed abstracts using a text-mining method referred in Wang <italic toggle="yes">et al.</italic> (<xref rid="R21" ref-type="bibr">21</xref>). Briefly, the trained immunity-related literature was collected by searching in the field ‘title/abstract’ in PubMed database using keyword ‘trained immunity’ and its lexical variants, including ‘trained innate immunity’, ‘trained effect’, ‘training effect’, ‘trained host defense’, ‘immune innate memory’, ‘innate immune memory’, ‘immune training’, ‘immune trained’ and ‘immune non-specific memory’. The obtained literature abstracts were retrieved using National Center for Biotechnology Information (NCBI) E-Utilities Application Programming Interface (API) (<xref rid="R22" ref-type="bibr">22</xref>). Then, trained immunity-related genes were identified and extracted using a custom bio-entity recognizer based on protein ontology, and only genes from three species (human, rat and mouse) were kept in our database. Finally, all remaining genes and the evidence sentences in which the gene and keyword co-occurred were manually validated by three rounds of manual curation: (i) all sentences with trained immunity-related genes were checked and selected by two experienced researchers independently; (ii) all the selected sentences were manually reviewed and approved by three experts and (iii) all coauthors were asked to randomly check the data from the website to ensure the correctness and quality of our database. In addition, basic information (such as symbol, synonyms and location in genomes) of genes in TIDB was retrieved from the NCBI gene database, and evidence was annotated with terms from the Evidence &amp; Conclusion Ontology (ECO) (<xref rid="R23" ref-type="bibr">23</xref>).</p>
      <fig position="float" id="F1" fig-type="figure">
        <label>Figure 1.</label>
        <caption>
          <p>The workflow of TIDB construction.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="baab041f1" position="float"/>
      </fig>
    </sec>
    <sec id="s1-s2">
      <title>Database overview and implementation</title>
      <p>An overview of TIDB is shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1</xref>. TIDB has been designed as a user-friendly web interface where users can search, browse, download and analyze trained immunity-related genes and literature evidence of human, rat and mouse. The website interface comprises five main pages including ‘Home’, ‘Browse &amp; Download’, ‘FAQ’, ‘Feedback’ and ‘Log in’. On the ‘Home page’, users can search for trained immunity-related genes. Then, users can perform three kinds of analysis, including Reactome pathway (<xref rid="R24" ref-type="bibr">24</xref>) over-representation analysis (ORA), Gene Ontology (GO) (<xref rid="R25" ref-type="bibr">25</xref>) enrichment analysis and protein–protein interaction (PPI) subnetwork reconstruction on genes of their interests. Users can browse and download all the trained immunity-related genes and the supporting literature evidence using the ‘Browse and Download’ page. The ‘FAQ’ page includes general questions and answers, which guide the users on how to use TIDB conveniently. On the ‘Feedback’ page, users can submit new genes to our database manually. Moreover, our website also provides manual annotation at the end of each evidence phrase, which requires user registration and login on the ‘Log in’ page.</p>
      <p>TIDB is hosted on an Apache webserver with MongoDB, NodeJS and eggJS in the back-end. The dynamic, interactive front-end of our database is developed using HTML5, CSS3 and JavaScript. Bootstrap and jQuery framework are used to generate a responsive interface. Cytoscape.js is used for PPI network visualization. We recommend using the latest versions of Chrome, Firefox or Safari web browser for the best experience. The source code of TIDB is freely available under Creative Commons license (CC BY-SA 4.0) at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/niuclab/TIDB" ext-link-type="uri">https://github.com/niuclab/TIDB</ext-link> for possible contribution, discussion and change tracking.</p>
    </sec>
    <sec id="s1-s3">
      <title>Data search and navigation</title>
      <p>TIDB provides a user-friendly web interface that allows searching and exploring information on trained immunity-related genes (<xref rid="F2 F2" ref-type="fig">Figure 2A and B</xref>). Gene symbols or gene synonyms are supported by a query in TIDB. After clicking the ‘Search’ button, the search engine will run and return the queried results as a three-column table containing gene symbol, organism, and the supporting literature evidence. By clicking the hyperlink of a gene symbol in the ‘Gene’ column of the search results, the user can obtain basic information for the trained immunity-related gene and cross-references to external databases (i.e. NCBI Entrez (<xref rid="R26" ref-type="bibr">26</xref>) and Ensembl (<xref rid="R27" ref-type="bibr">27</xref>), <xref rid="F3" ref-type="fig">Figure. 3B</xref>). When clicking the hyperlink of literature evidence, the whole abstract will be represented in which the evidence sentence, keywords and gene names are highlighted (<xref rid="F3" ref-type="fig">Figure 3A</xref>). All information for trained immunity-related genes and their supporting literature evidence are listed in the ‘Browser &amp; Download’ page and can be downloaded easily.</p>
      <fig position="float" id="F2" fig-type="figure">
        <label>Figure 2.</label>
        <caption>
          <p>Screenshots of search box at home page (A), search results (B) and the three analysis modules (C).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="baab041f2" position="float"/>
      </fig>
      <fig position="float" id="F3" fig-type="figure">
        <label>Figure 3.</label>
        <caption>
          <p>Screenshots of literature evidence page (A) and gene information page (B).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="baab041f3" position="float"/>
      </fig>
    </sec>
    <sec id="s1-s4">
      <title>Analyzer</title>
      <p>Once the data search process is completed, by selecting the genes of interest from the search results, users can use three analytical tools to conduct further analysis and reveal the interesting results behind these genes (<xref rid="F2 F4" ref-type="fig">Figure 2C, Figure 4</xref>). Reactome pathway ORA and GO enrichment analysis were provided to test the probability that genes of interest are over-represented in Reactome pathways and GO terms PPI subnetwork reconstruction can be used to identify molecular interactions, predict protein functions, analyze functional modules and discover hub regulatory genes of disease (<xref rid="R28" ref-type="bibr">28</xref>). For more details on how to analyze the genes of interest and interpret the analysis results, see the manual of TIDB (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ieom-tm.com/tidb/help" ext-link-type="uri">http://www.ieom-tm.com/tidb/help</ext-link>).</p>
      <fig position="float" id="F4" fig-type="figure">
        <label>Figure 4.</label>
        <caption>
          <p>Screenshots of the results of three analysis modules, Reactome pathway ORA (A), GO enrichment analysis (B) and PPI network reconstruction (C).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="baab041f4" position="float"/>
      </fig>
    </sec>
    <sec id="s1-s5">
      <title>Reactome pathway ORA and GO enrichment analysis</title>
      <p>Reactome pathway ORA and GO enrichment analysis were used to discover which pathways and GO terms are associated with the selected genes. The hypergeometric test (or Fisher’s exact test) followed by a correction for multiple hypothesis testing using the false discovery rate (FDR) method was employed to calculate the probability of enriched term.</p>
      <p>Pathway ORA has a broad range of applications in life sciences and medical research. Reactome is an open source of manually curated pathway database for unveiling the mechanisms and small molecules involved in high-order biological pathways. TIDB integrates the pathway over-representation analysis via the Reactome web service. Once this analysis is complete, analysis results are shown in the ‘Reactome Analysis’ tab, within the ‘Details Panel’ (<xref rid="F4" ref-type="fig">Figure 4A</xref>). All Reactome pathways are shown in blocks of 20 pathways, ranked by the <italic toggle="yes">P</italic>-value obtained from ORA.</p>
      <p>GO is the most comprehensive and widely used knowledgebase for functional studies of genes. GO covers three distinct aspects of gene function, namely, biological processes (BP), cellular components (CC) and molecular functions (MF) (<xref rid="R29" ref-type="bibr">29</xref>). GO enrichment analysis has become a common method for the functional study of gene sets and can be used to gain insights into the BP they are involved in. This tool requires users to specify the species, the category of ontology (BP, CC or MF), P-value cutoff, and to check whether to perform the FDR correction for multiple hypothesis testing. The enriched GO terms will be visualized and a table containing the details of the enriched GO term, and IDs of genes of interest mapped to the GO term, <italic toggle="yes">P</italic>-value and q value (FDR corrected <italic toggle="yes">P</italic> value) will be displayed on the result page (<xref rid="F4" ref-type="fig">Figure 4B</xref>). The details of the enriched GO terms can be downloaded as a csv-formatted file.</p>
      <p>We examined the function of the trained immunity-related genes of human by performing Reactome pathway ORA and GO enrichment analysis. As a result, the most enriched Reactome pathways are cytokine interleukin-related pathways (e.g. interleukin-10 signaling, interleukin-4 and interleukin-13 signaling) and toll-like receptor (TLR) cascades-related pathways (e.g. TLR6:TLR2 Cascade, TLR 2 Cascade) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>); the most enriched GO BP terms are positive regulation of cytokine production, bacteria-related terms, (e.g. response to molecule of bacterial origin, response to lipopolysaccharide) and cellular response to biotic stimulus (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S2</xref>). It should be mentioned that the cytokines are mainly secreted by innate immune cells (e.g. monocytes and macrophages), and TLR forms the cornerstone of the innate immune response (<xref rid="R30" ref-type="bibr">30</xref>). Moreover, receptors of bacteria, such as TLR and lipopolysaccharide, are mainly expressed on innate immune cells (<xref rid="R31" ref-type="bibr">31</xref>). These results suggest that the most enriched functional terms for trained immunity-related genes are all associated with innate immune response, which is consistent with above mentioned that trained immunity is a special program of innate immunity memory.</p>
    </sec>
    <sec id="s1-s6">
      <title>PPI subnetwork reconstruction</title>
      <p>PPI subnetwork analysis was implemented to uncover the insightful landscape of the molecular interactions and topological attributes for the selected trained immunity-related genes. For PPI subnetwork reconstruction, we first downloaded the reference PPI data of human, rat and mouse from the IntAct database (<xref rid="R32" ref-type="bibr">32</xref>). Then, the PPI subnetwork, which was centered on the seed proteins with the largest average clustering coefficient was constructed via random walking with restart (RWR) approach (<xref rid="R33" ref-type="bibr">33</xref>). This tool requires users to specify the number of random walk steps of RWR, the species and the edge weight cutoff used to subset the IntAct PPI network. As a result, the PPI network, in which the interest genes are filled in red, will display on the result page (<xref rid="F4" ref-type="fig">Figure 4C</xref>). Moreover, the network can be saved as the SVG format, and the edge lists can be exported in CSV format.</p>
    </sec>
    <sec id="s1-s7">
      <title>Feedback</title>
      <p>TIDB provides a feedback feature that allows users to submit new trained immunity-related genes and the corresponding literature evidence manually on the ‘Feedback’ page. In addition, TIDB also provides manual annotation at the end of each evidence phrase, by which users can confirm the evidence or deny it by simply clicking the ‘Yes’ or ‘No’ button to confirm or reject the evidence phrase after login as registered users.</p>
    </sec>
  </sec>
  <sec id="s2">
    <title>Discussion and future directions</title>
    <p>Increasing evidence has proven that trained immunity-related genes play an important role in health and disease, but the information of the previously identified trained immunity-related genes is scattered in numerous pieces of literature. In this study, we developed TIDB, an open source and comprehensive database of trained immunity-related genes. The trained immunity-related genes were identified using an in-house ontology-based bio-entity recognizer from the abstracts of all publications from PubMed with the keyword ‘trained immunity’ and its lexical variants. TIDB is the first extensive database that provides details on trained immunity-related genes in human, rat and mouse as well as the literature evidence and integrates three analysis modules (Reactome pathway ORA, GO enrichment analysis and PPI subnetwork reconstruction). It allows users to search and download information about trained immunity-related genes freely and easily. We believe that this database can contribute significantly to the understanding of the role of trained immunity in health and disease.</p>
    <p>In the future, we will continue to identify and collect more trained immunity-related genes and improve TIDB to provide more accurate information. We will also update our database periodically to include feedback from the users.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>baab041_Supp</label>
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="baab041_supp.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>The authors appreciate the members of the Niu lab who helped to test TIDB and provided valuable feedback.</p>
  </ack>
  <sec id="s3">
    <title>Supplementary data</title>
    <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Database</italic> online.</p>
  </sec>
  <sec id="s4">
    <title>Funding</title>
    <p>This work has been supported by the Tianjin Institute of Environmental and Operational Medicine [BWS17J025, BWS17J031].</p>
  </sec>
  <sec id="s5">
    <title>Conflict of interest.</title>
    <p>None declared.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="R1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Netea</surname><given-names>M.G.</given-names></string-name>, <string-name><surname>Quintin</surname><given-names>J.</given-names></string-name> and <string-name><surname>van der Meer</surname><given-names>J.W.M.</given-names></string-name></person-group> (<year>2011</year>) <article-title>Trained immunity: a memory for innate host defense</article-title>. <source><italic toggle="yes">Cell Host Microbe</italic></source>, <volume>9</volume>, <fpage>355</fpage>–<lpage>361</lpage>.<pub-id pub-id-type="pmid">21575907</pub-id></mixed-citation>
    </ref>
    <ref id="R2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Netea</surname><given-names>M.G.</given-names></string-name>, <string-name><surname>Domínguez-Andrés</surname><given-names>J.</given-names></string-name>, <string-name><surname>Barreiro</surname><given-names>L.B.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>Defining trained immunity and its role in health and disease</article-title>. <source><italic toggle="yes">Nat. Rev. Immunol.</italic></source>, <volume>20</volume>, <fpage>375</fpage>–<lpage>388</lpage>.<pub-id pub-id-type="pmid">32132681</pub-id></mixed-citation>
    </ref>
    <ref id="R3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Naik</surname><given-names>S.</given-names></string-name>, <string-name><surname>Larsen</surname><given-names>S.B.</given-names></string-name>, <string-name><surname>Gomez</surname><given-names>N.C.</given-names></string-name></person-group><etal>et al.</etal> (<year>2017</year>) <article-title>Inflammatory memory sensitizes skin epithelial stem cells to tissue damage</article-title>. <source><italic toggle="yes">Nature</italic></source>, <volume>550</volume>, <fpage>475</fpage>–<lpage>480</lpage>.<pub-id pub-id-type="pmid">29045388</pub-id></mixed-citation>
    </ref>
    <ref id="R4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Christ</surname><given-names>A.</given-names></string-name>, <string-name><surname>Günther</surname><given-names>P.</given-names></string-name>, <string-name><surname>Lauterbach</surname><given-names>M.A.R.</given-names></string-name></person-group><etal>et al.</etal> (<year>2018</year>) <article-title>Western diet triggers NLRP3-dependent innate immune reprogramming</article-title>. <source><italic toggle="yes">Cell</italic></source>, <volume>172</volume>, <fpage>162</fpage>–<lpage>175</lpage>. e14.<pub-id pub-id-type="pmid">29328911</pub-id></mixed-citation>
    </ref>
    <ref id="R5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Braza</surname><given-names>M.S.</given-names></string-name>, <string-name><surname>van Leent</surname><given-names>M.M.T.</given-names></string-name>, <string-name><surname>Lameijer</surname><given-names>M.</given-names></string-name></person-group><etal>et al.</etal> (<year>2018</year>) <article-title>Inhibiting inflammation with myeloid cell-specific nanobiologics promotes organ transplant acceptance</article-title>. <source><italic toggle="yes">Immunity</italic></source>, <volume>49</volume>, <fpage>819</fpage>–<lpage>828</lpage>. e6.<pub-id pub-id-type="pmid">30413362</pub-id></mixed-citation>
    </ref>
    <ref id="R6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Covián</surname><given-names>C.</given-names></string-name>, <string-name><surname>Fernández-Fierro</surname><given-names>A.</given-names></string-name>, <string-name><surname>Retamal-Díaz</surname><given-names>A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2019</year>) <article-title>BCG-induced cross-protection and development of trained immunity: implication for vaccine design</article-title>. <source><italic toggle="yes">Front. Immunol.</italic></source>, <volume>10</volume>, <fpage>1</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">30723466</pub-id></mixed-citation>
    </ref>
    <ref id="R7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jeyanathan</surname><given-names>M.</given-names></string-name>, <string-name><surname>Yao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Afkhami</surname><given-names>S.</given-names></string-name></person-group><etal>et al.</etal> (<year>2018</year>) <article-title>New tuberculosis vaccine strategies: taking aim at un-natural immunity</article-title>. <source><italic toggle="yes">Trends Immunol.</italic></source>, <volume>39</volume>, <fpage>419</fpage>–<lpage>433</lpage>.<pub-id pub-id-type="pmid">29429859</pub-id></mixed-citation>
    </ref>
    <ref id="R8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Netea</surname><given-names>M.G.</given-names></string-name>, <string-name><surname>Giamarellos-Bourboulis</surname><given-names>E.J.</given-names></string-name>, <string-name><surname>Domínguez-Andrés</surname><given-names>J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection</article-title>. <source><italic toggle="yes">Cell</italic></source>, <volume>181</volume>, <fpage>969</fpage>–<lpage>977</lpage>.<pub-id pub-id-type="pmid">32437659</pub-id></mixed-citation>
    </ref>
    <ref id="R9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Jeyanathan</surname><given-names>M.</given-names></string-name>, <string-name><surname>Haddadi</surname><given-names>S.</given-names></string-name></person-group><etal>et al.</etal> (<year>2018</year>) <article-title>Induction of autonomous memory alveolar macrophages requires T cell help and is critical to trained immunity</article-title>. <source><italic toggle="yes">Cell</italic></source>, <volume>175</volume>, <fpage>1634</fpage>–<lpage>1650</lpage>. e17.<pub-id pub-id-type="pmid">30433869</pub-id></mixed-citation>
    </ref>
    <ref id="R10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Arts</surname><given-names>R.J.W.</given-names></string-name>, <string-name><surname>Moorlag</surname><given-names>S.J.C.F.M.</given-names></string-name>, <string-name><surname>Novakovic</surname><given-names>B.</given-names></string-name></person-group><etal>et al.</etal> (<year>2018</year>) <article-title>BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity</article-title>. <source><italic toggle="yes">Cell Host Microbe</italic></source>, <volume>23</volume>, <fpage>89</fpage>–<lpage>100</lpage>. e5.<pub-id pub-id-type="pmid">29324233</pub-id></mixed-citation>
    </ref>
    <ref id="R11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rabold</surname><given-names>K.</given-names></string-name>, <string-name><surname>Netea</surname><given-names>M.G.</given-names></string-name>, <string-name><surname>Adema</surname><given-names>G.J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2017</year>) <article-title>Cellular metabolism of tumor-associated macrophages – functional impact and consequences</article-title>. <source><italic toggle="yes">FEBS Lett.</italic></source>, <volume>591</volume>, <fpage>3022</fpage>–<lpage>3041</lpage>.<pub-id pub-id-type="pmid">28771701</pub-id></mixed-citation>
    </ref>
    <ref id="R12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hodge</surname><given-names>D.R.</given-names></string-name>, <string-name><surname>Hurt</surname><given-names>E.M.</given-names></string-name> and <string-name><surname>Farrar</surname><given-names>W.L.</given-names></string-name></person-group> (<year>2005</year>) <article-title>The role of IL-6 and STAT3 in inflammation and cancer</article-title>. <source><italic toggle="yes">Eur. J. Cancer</italic></source>, <volume>41</volume>, <fpage>2502</fpage>–<lpage>2512</lpage>.<pub-id pub-id-type="pmid">16199153</pub-id></mixed-citation>
    </ref>
    <ref id="R13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname><given-names>S.H.</given-names></string-name>, <string-name><surname>Hong</surname><given-names>H.S.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Z.X.</given-names></string-name></person-group><etal>et al.</etal> (<year>2012</year>) <article-title>TNFα enhances cancer stem cell-like phenotype via Notch-Hes1 activation in oral squamous cell carcinoma cells</article-title>. <source><italic toggle="yes">Biochem. Biophys. Res. Commun.</italic></source>, <volume>424</volume>, <fpage>58</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="pmid">22728043</pub-id></mixed-citation>
    </ref>
    <ref id="R14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Krawczyk</surname><given-names>C.M.</given-names></string-name>, <string-name><surname>Holowka</surname><given-names>T.</given-names></string-name>, <string-name><surname>Sun</surname><given-names>J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2010</year>) <article-title>Toll-like receptor–induced changes in glycolytic metabolism regulate dendritic cell activation</article-title>. <source><italic toggle="yes">Blood</italic></source>, <volume>115</volume>, <fpage>4742</fpage>–<lpage>4749</lpage>.<pub-id pub-id-type="pmid">20351312</pub-id></mixed-citation>
    </ref>
    <ref id="R15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cheng</surname><given-names>S.-C.</given-names></string-name>, <string-name><surname>Quintin</surname><given-names>J.</given-names></string-name>, <string-name><surname>Cramer</surname><given-names>R.A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2014</year>) <article-title>mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity</article-title>. <source><italic toggle="yes">Science</italic></source>, <volume>345</volume>, <fpage>1</fpage>–<lpage>8</lpage>.</mixed-citation>
    </ref>
    <ref id="R16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Arts</surname><given-names>R.J.W.</given-names></string-name>, <string-name><surname>Carvalho</surname><given-names>A.</given-names></string-name>, <string-name><surname>La Rocca</surname><given-names>C.</given-names></string-name></person-group><etal>et al.</etal> (<year>2016</year>) <article-title>Immunometabolic pathways in BCG-induced trained immunity</article-title>. <source><italic toggle="yes">Cell Rep.</italic></source>, <volume>17</volume>, <fpage>2562</fpage>–<lpage>2571</lpage>.<pub-id pub-id-type="pmid">27926861</pub-id></mixed-citation>
    </ref>
    <ref id="R17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Arts</surname><given-names>R.J.W.</given-names></string-name>, <string-name><surname>Novakovic</surname><given-names>B.</given-names></string-name>, <string-name><surname>ter Horst</surname><given-names>R.</given-names></string-name></person-group><etal>et al.</etal> (<year>2016</year>) <article-title>Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity</article-title>. <source><italic toggle="yes">Cell Metab.</italic></source>, <volume>24</volume>, <fpage>807</fpage>–<lpage>819</lpage>.<pub-id pub-id-type="pmid">27866838</pub-id></mixed-citation>
    </ref>
    <ref id="R18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Jørgensen</surname><given-names>P.F.</given-names></string-name>, <string-name><surname>Ellingsen</surname><given-names>E.A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2001</year>) <article-title>Peptidoglycan primes for LPS-induced release of proinflammatory cytokines in whole human blood</article-title>. <source><italic toggle="yes">Shock</italic></source>, <volume>16</volume>, <fpage>178</fpage>–<lpage>182</lpage>.<pub-id pub-id-type="pmid">11531018</pub-id></mixed-citation>
    </ref>
    <ref id="R19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wray</surname><given-names>G.M.</given-names></string-name>, <string-name><surname>Foster</surname><given-names>S.J.</given-names></string-name>, <string-name><surname>Hinds</surname><given-names>C.J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2001</year>) <article-title>A cell wall component from pathogenic and non-pathogenic gram-positive bacteria (peptidoglycan) synergises with endotoxin to cause the release of tumour necrosis factor-alpha, nitric oxide production, shock, and multiple organ injury/dysfunction in the rat</article-title>. <source><italic toggle="yes">Shock</italic></source>, <volume>15</volume>, <fpage>135</fpage>–<lpage>142</lpage>.<pub-id pub-id-type="pmid">11220642</pub-id></mixed-citation>
    </ref>
    <ref id="R20">
      <label>20.</label>
      <mixed-citation publication-type="other"><person-group person-group-type="author"><collab>US Library of Medicine</collab></person-group>. (<year>2013</year>) <article-title>Beta-glucan and monoclonal antibody in treating patients with metastatic neuroblastoma</article-title>.</mixed-citation>
    </ref>
    <ref id="R21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>P.</given-names></string-name></person-group><etal>et al.</etal> (<year>2017</year>) <article-title>AAgAtlas 1.0: a human autoantigen database</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>45</volume>, D<fpage>769</fpage>–<lpage>776</lpage>.</mixed-citation>
    </ref>
    <ref id="R22">
      <label>22.</label>
      <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Sayers</surname><given-names>E.</given-names></string-name></person-group> (<year>2018</year>) <article-title>E-utilities quick start</article-title>. <publisher-name>National Center for Biotechnology Information (US)</publisher-name>.</mixed-citation>
    </ref>
    <ref id="R23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Giglio</surname><given-names>M.</given-names></string-name>, <string-name><surname>Tauber</surname><given-names>R.</given-names></string-name>, <string-name><surname>Nadendla</surname><given-names>S.</given-names></string-name></person-group><etal>et al.</etal> (<year>2019</year>) <article-title>ECO, the Evidence &amp; Conclusion Ontology: community standard for evidence information</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>47</volume>, D<fpage>1186</fpage>–<lpage>1194</lpage>.</mixed-citation>
    </ref>
    <ref id="R24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jassal</surname><given-names>B.</given-names></string-name>, <string-name><surname>Matthews</surname><given-names>L.</given-names></string-name>, <string-name><surname>Viteri</surname><given-names>G.</given-names></string-name></person-group><etal>et al.</etal> (<year>2020</year>) <article-title>The reactome pathway knowledgebase</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>48</volume>, D<fpage>498</fpage>–<lpage>503</lpage>.</mixed-citation>
    </ref>
    <ref id="R25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ashburner</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ball</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>Blake</surname><given-names>J.A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2000</year>) <article-title>Gene Ontology: tool for the unification of biology</article-title>. <source><italic toggle="yes">Nat. Genet.</italic></source>, <volume>25</volume>, <fpage>25</fpage>–<lpage>29</lpage>.<pub-id pub-id-type="pmid">10802651</pub-id></mixed-citation>
    </ref>
    <ref id="R26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maglott</surname><given-names>D.</given-names></string-name>, <string-name><surname>Ostell</surname><given-names>J.</given-names></string-name>, <string-name><surname>Pruitt</surname><given-names>K.D.</given-names></string-name></person-group><etal>et al.</etal> (<year>2011</year>) <article-title>Entrez gene: gene-centered information at NCBI</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>39</volume>, D<fpage>52</fpage>–<lpage>57</lpage>.</mixed-citation>
    </ref>
    <ref id="R27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aken</surname><given-names>B.L.</given-names></string-name>, <string-name><surname>Ayling</surname><given-names>S.</given-names></string-name>, <string-name><surname>Barrell</surname><given-names>D.</given-names></string-name></person-group><etal>et al.</etal> (<year>2016</year>) <article-title>The Ensembl gene annotation system</article-title>. <source><italic toggle="yes">Database (Oxford)</italic></source>, <volume>2016</volume>, <fpage>1</fpage>–<lpage>19</lpage>.</mixed-citation>
    </ref>
    <ref id="R28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Peng</surname><given-names>X.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Peng</surname><given-names>W.</given-names></string-name></person-group><etal>et al.</etal> (<year>2017</year>) <article-title>Protein–protein interactions: detection, reliability assessment and applications</article-title>. <source><italic toggle="yes">Brief. Bioinformatics</italic></source>, <volume>18</volume>, <fpage>798</fpage>–<lpage>819</lpage>.<pub-id pub-id-type="pmid">27444371</pub-id></mixed-citation>
    </ref>
    <ref id="R29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Gene Ontology Consortium</collab></person-group>. (<year>2019</year>) <article-title>The Gene Ontology resource: 20 years and still GOing strong</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>47</volume>, D<fpage>330</fpage>–<lpage>338</lpage>.</mixed-citation>
    </ref>
    <ref id="R30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Medzhitov</surname><given-names>R.</given-names></string-name></person-group> (<year>2001</year>) <article-title>Toll-like receptors and innate immunity</article-title>. <source><italic toggle="yes">Nat. Rev. Immunol.</italic></source>, <volume>1</volume>, <fpage>135</fpage>–<lpage>145</lpage>.<pub-id pub-id-type="pmid">11905821</pub-id></mixed-citation>
    </ref>
    <ref id="R31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tsukasaki</surname><given-names>M.</given-names></string-name> and <string-name><surname>Takayanagi</surname><given-names>H.</given-names></string-name></person-group> (<year>2019</year>) <article-title>Osteoimmunology: evolving concepts in bone–immune interactions in health and disease</article-title>. <source><italic toggle="yes">Nat. Rev. Immunol.</italic></source>, <volume>19</volume>, <fpage>626</fpage>–<lpage>642</lpage>.<pub-id pub-id-type="pmid">31186549</pub-id></mixed-citation>
    </ref>
    <ref id="R32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Orchard</surname><given-names>S.</given-names></string-name>, <string-name><surname>Ammari</surname><given-names>M.</given-names></string-name>, <string-name><surname>Aranda</surname><given-names>B.</given-names></string-name></person-group><etal>et al.</etal> (<year>2014</year>) <article-title>The MIntAct project—IntAct as a common curation platform for 11 molecular interaction databases</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>42</volume>, D<fpage>358</fpage>–<lpage>363</lpage>.</mixed-citation>
    </ref>
    <ref id="R33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Köhler</surname><given-names>S.</given-names></string-name>, <string-name><surname>Bauer</surname><given-names>S.</given-names></string-name>, <string-name><surname>Horn</surname><given-names>D.</given-names></string-name></person-group><etal>et al.</etal> (<year>2008</year>) <article-title>Walking the interactome for prioritization of candidate disease genes</article-title>. <source><italic toggle="yes">Am. J. Hum. Genet.</italic></source>, <volume>82</volume>, <fpage>949</fpage>–<lpage>958</lpage>.<pub-id pub-id-type="pmid">18371930</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
